BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33621527)

  • 1. Apolipoprotein M Gene Polymorphism Rs805297 (C-1065A): Association With Type 2 Diabetes Mellitus and Related Microvascular Complications in South Egypt.
    Tageldeen MM; Badrawy H; Abdelmeguid M; Zaghlol M; Gaber N; Kenawy EM
    Am J Med Sci; 2021 Jul; 362(1):48-55. PubMed ID: 33621527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-nucleotide polymorphism C-724 /del in the proter region of the apolipoprotein M gene is associated with type 2 diabetes mellitus.
    Zhang PH; Gao JL; Pu C; Feng G; Wang LZ; Huang LZ; Zhang Y
    Lipids Health Dis; 2016 Aug; 15(1):142. PubMed ID: 27576735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction Between Apolipoprotein M Gene Single-Nucleotide Polymorphisms and Obesity and its Effect on Type 2 Diabetes Mellitus Susceptibility.
    Liu D; Pan JM; Pei X; Li JS
    Sci Rep; 2020 May; 10(1):7859. PubMed ID: 32398715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-nucleotide polymorphism in the proximal promoter region of the apolipoprotein M gene is associated with dyslipidaemia but not increased coronary artery diseases in Chinese populations.
    Cao B; Ye YZ; Rui J; Li MQ; Wang W; Wei LY; Jiao GQ
    Lipids Health Dis; 2013 Dec; 12():184. PubMed ID: 24341666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese.
    Niu N; Zhu X; Liu Y; Du T; Wang X; Chen D; Sun B; Gu HF; Liu Y
    Diabetes Metab Res Rev; 2007 Jan; 23(1):21-5. PubMed ID: 16572495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein M and Risk of Type 2 Diabetes.
    Hajny S; Christoffersen M; Dalila N; Nielsen LB; Tybjærg-Hansen A; Christoffersen C
    J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32621749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Dahlbäck B; Svensson PJ; Sundquist J; Memon AA
    Thromb Haemost; 2016 Aug; 116(3):432-41. PubMed ID: 27277397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein m (APOM) levels and APOM rs805297 G/T polymorphism are associated with increased risk of rheumatoid arthritis.
    Huang Y; Liu Y; Jiang L; Sun R; Zhang H; Liu R; Xu N
    Joint Bone Spine; 2014 Jan; 81(1):32-6. PubMed ID: 23660425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low apolipoprotein M serum levels correlate with Systemic lupus erythematosus disease activity and apolipoprotein M gene polymorphisms with Lupus.
    Du W; Shen T; Li H; Liu Y; He L; Tan L; Hu M; Ren Y
    Lipids Health Dis; 2017 May; 16(1):88. PubMed ID: 28476116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein M gene (APOM) polymorphism modifies metabolic and disease traits in type 2 diabetes.
    Zhou JW; Tsui SK; Ng MC; Geng H; Li SK; So WY; Ma RC; Wang Y; Tao Q; Chen ZY; Chan JC; Ho YY
    PLoS One; 2011 Feb; 6(2):e17324. PubMed ID: 21390319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study the Association of Tumor Necrosis Factor Promoter Polymorphism with Type 2 Diabetic Nephropathy.
    Emara M; El-Edel R; Fathy WM; Aboelkhair NT; Watany MM; Abou-Elela DH
    Mediators Inflamm; 2020; 2020():1498278. PubMed ID: 32684830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCF7L2 gene polymorphism as a risk for type 2 diabetes mellitus and diabetic microvascular complications.
    Aboelkhair NT; Kasem HE; Abdelmoaty AA; El-Edel RH
    Mol Biol Rep; 2021 Jun; 48(6):5283-5290. PubMed ID: 34232465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MCP-1 Gene A-2518G Polymorphism Confers an Increased Risk of Vascular Complications in Type 2 Diabetes Mellitus Patients.
    Xu J; Liao YF; Zhou WP; Ming HL; Wang QH
    Genet Test Mol Biomarkers; 2015 Aug; 19(8):411-7. PubMed ID: 26083329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common variants at the promoter region of the APOM confer a risk of rheumatoid arthritis.
    Hu HJ; Jin EH; Yim SH; Yang SY; Jung SH; Shin SH; Kim WU; Shim SC; Kim TG; Chung YJ
    Exp Mol Med; 2011 Nov; 43(11):613-21. PubMed ID: 21844665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of incretin receptors genetic polymorphisms with type 2 diabetes mellitus in Egyptian patients.
    Shalaby SM; Zidan HE; Shokry A; Saeed J; El-Sokkary RH
    J Gene Med; 2017 Sep; 19(9-10):. PubMed ID: 28744963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients.
    Bansal S; Chawla D; Banerjee BD; Madhu SV; Tripathi AK
    Gene; 2013 Sep; 526(2):325-30. PubMed ID: 23721855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of irisin and FNDC5 rs16835198 G>T gene polymorphism with type 2 diabetes mellitus and diabetic nephropathy. An Egyptian pilot study.
    Khidr EG; Ali SS; Elshafey MM; Fawzy OA
    Gene; 2017 Aug; 626():26-31. PubMed ID: 28479383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of apolipoprotein M gene polymorphisms with ischemic stroke in a Han Chinese population.
    Zhao D; He Z; Qin X; Li L; Liu F; Deng S
    J Mol Neurosci; 2011 Mar; 43(3):370-5. PubMed ID: 20872094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease.
    El-Lebedy D; Raslan HM; Mohammed AM
    Cardiovasc Diabetol; 2016 Jan; 15():12. PubMed ID: 26800892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The APOM polymorphism as a novel risk factor for dyslipidaemia in rheumatoid arthritis: a possible shared link between disease susceptibility and dyslipidaemia.
    Park YJ; Yoo SA; Lee JH; Chung YJ; Cho CS; Kim W-
    Clin Exp Rheumatol; 2013; 31(2):180-8. PubMed ID: 23190940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.